- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05705596
Impact of Hesperetin in Combination With Sucrose on Energy Metabolism
Einfluss Des süßmodulierenden Polyphenols Hesperetin in Kombination Mit Saccharose Auf Die Blutglukose-Regulierung Und Energieaufnahme in Abhängigkeit Der Süßwahrnehmung
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study is designed as a randomised cross-over intervention study with two arms. The aim is to investigate the influence of a 10% sucrose solution, corresponding to the sugar content of a conventional soft drink, compared to an equally sweet-tasting 7% sucrose solution in combination with 50 mg/L of the polyphenol hesperetin, on time-dependent blood glucose fluctuations and ad libitum energy intake in metabolically healthy male volunteers.
To investigate the underlying mechanisms, the individual appetite score, metabolic and hormonal responses to the interventions and circulating extracellular vesicles and their miRNA composition will be measured. In addition, the participants' individual thresholds for sweet taste, preference and consumption for sweet-tasting foods such as sugar and sweeteners, and their body composition will be recorded as potential influencing factors.
Study Type
Enrollment (Actual)
Phase
- Early Phase 1
Contacts and Locations
Study Locations
-
-
-
Vienna, Austria, 1090
- Christian Doppler Laboratory for Taste Research
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- male
- healthy
- non-smoking
- normal taste responses towards sweet taste
Exclusion Criteria:
- female
- regular smokers
- disturbed glucose and/or lipid metabolism
- regular intake of medication
- known allergies against one of the test compounds
- ageusia
- alcohol or drug addiction
- intake of antibiotics within the past 2 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Sucrose
10% (w/v) sucrose in water
|
10% sucrose corresponding to a regular soft drink
Other Names:
|
Experimental: Hesperetin
7% (w/v) sucrose in water + 50 mg/L Hesperetin
|
increases sweetness of 7% sucrose solution to match sweetness of 10% sucrose solution
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in blood glucose concentration
Time Frame: 15, 30, 60, 90, and 120 minutes after drinking the test solution
|
Change compared to baseline in blood glucose concentration [mg/dL] in plasma samples after drinking the test solution
|
15, 30, 60, 90, and 120 minutes after drinking the test solution
|
Change in appetite score
Time Frame: Difference between before and 120 minutes after drinking of the test solution
|
Change compared to baseline in the subjective rating of the individual feeling of hunger, fullness, as well as appetite for a snack or for something sweet on a digital visual analog scale in comparison to baseline
|
Difference between before and 120 minutes after drinking of the test solution
|
Change in food intake
Time Frame: 120 minutes after drinking of the test solution
|
Ad libitum food intake from a standardized breakfast
|
120 minutes after drinking of the test solution
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in blood glucose regulating hormones
Time Frame: 15, 30, 60, 90, and 120 minutes after drinking the test solution
|
Change compared to baseline in Insulin, Glucagon-like peptide 1, and Gastric inhibitory polypeptide concentrations [mmol/L] in plasma samples after drinking the test solution
|
15, 30, 60, 90, and 120 minutes after drinking the test solution
|
Change in satiety hormones
Time Frame: 15, 30, 60, 90, and 120 minutes after drinking the test solution
|
Change compared to baseline in Polypeptide Y, grehlin, cholecystokinin, and serotonin concentrations [mmol/L] in plasma samples after drinking the test
|
15, 30, 60, 90, and 120 minutes after drinking the test solution
|
Change in circulating miRNA
Time Frame: 15, 30, 60, 90, and 120 minutes after drinking the test solution
|
Change compared to baseline in circulating extracellular vesicles and their miRNA composition
|
15, 30, 60, 90, and 120 minutes after drinking the test solution
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Barbara Lieder, PhD, University of Vienna
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 706014-2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hunger
-
Clinical Nutrition Research Center, Illinois Institute...Wm. Wrigley Jr. CompanyCompleted
-
Universitaire Ziekenhuizen KU LeuvenCompleted
-
Swansea UniversityCompletedHungerUnited Kingdom
-
Procter and GambleCompleted
-
Pennington Biomedical Research CenterAmerican Egg BoardCompleted
-
ImeldaziekenhuisCompleted
-
Karolinska InstitutetCompleted
-
Zoe Global LimitedActive, not recruiting
Clinical Trials on Sucrose
-
University of CopenhagenCompleted
-
Anderson Advanced IngredientsINQUIS Clinical Research Ltd.Completed
-
Yale UniversityCompletedInsulin Resistance | Impairment of Oral PerceptionUnited States
-
Lady Hardinge Medical CollegeCompletedPain in Preterm NeonatesIndia
-
Milton S. Hershey Medical CenterChildren's Miracle NetworkCompletedPain | Procedural PainUnited States
-
Clinical Nutrition Research Centre, SingaporeCompletedObesity | Type 2 Diabetes | Pre DiabetesSingapore
-
Oihana Lopez AlonsoCompleted
-
Beneo-InstituteCompleted
-
Northumbria UniversityUnknownMetabolic Disturbance | Dietary ExposureUnited Kingdom
-
QOL Medical, LLCCompletedCongenital Sucrase-Isomaltase DeficiencyUnited States